Endocrine disruption: Fact or urban legend?

Toxicology Letters

Volumn 223, Issue 3, 2013, Pages 295-305

  Nohynek, Gerhard J ^a   Borgert, Christopher J ^b   Dietrich, Daniel ^c   Rozman, Karl K ^d  

^a Les Caillons ^*  (France)

^b University of Florida College of Veterinary Medicine   (United States)

^c UNIVERSITY OF KONSTANZ   (Germany)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Additive effects; Endocrine disruptors; Personal care products; Potency; Testicular dysgenesis syndrome

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 HYDROXYBENZOIC ACID; 4 HYDROXYBENZOIC ACID ESTER; 4,4' ISOPROPYLIDENEDIPHENOL; ANTIPERSPIRANT AGENT; BENZYL PARABEN; BETA HEXACHLOROCYCLOHEXANE; BUTYL PARABEN; CHEMICAL COMPOUND; COUMESTROL; DAIDZEIN; DEODORANT AGENT; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTRADIOL; ESTRONE; ETHINYLESTRADIOL; GENISTEIN; HORMONE DERIVATIVE; METHOXYCHLOR; ORAL CONTRACEPTIVE AGENT; PHTHALIC ACID; PHTHALIC ACID DIBUTYL ESTER; PHTHALIC ACID DIETHYL ESTER; POLYCHLORINATED BIPHENYL; PROPYL PARABEN;

ADVERSE OUTCOME; ARTICLE; BIOLOGICAL ACTIVITY; BREAST CANCER; CRYPTORCHISM; DEL CASTILLO SYNDROME; DISEASE ASSOCIATION; ENDOCRINE FUNCTION; ENVIRONMENTAL HEALTH; ESTROGEN ACTIVITY; HEALTH HAZARD; HORMONE ACTION; HUMAN; HYPOSPADIAS; HYPOTHESIS; MALE FERTILITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SCREENING TEST; SPERMATOZOON COUNT; TESTIS CANCER; TESTIS DISEASE;

4-MBC; 4-METHYLBENZYLIDENE CAMPHOR; ADDITIVE EFFECTS; BFR; BUNDESAMT FÜR RISIKOBEWERTUNG (BERLIN, GERMANY); DEP; DES; DIETHYLPHTHALATE; DIETHYLSTILBESTROL; ECETOC; ED; EDC; EFSA; ENDOCRINE DISRUPTING CHEMICAL; ENDOCRINE DISRUPTOR; ENDOCRINE DISRUPTORS; EPA; EU; EUROPEAN CENTRE FOR ECOTOXICOLOGY AND TOXICOLOGY OF CHEMICALS; EUROPEAN FOOD SAFETY AGENCY; EUROPEAN UNION; GLP; GOOD LABORATORY PRACTICE; INTERNATIONAL PROGRAM ON CHEMICAL SAFETY; IPCS; PCP; PERSONAL CARE PRODUCTS; PERSONAL CARE PRODUCTS/COSMETICS; POTENCY; TDS; TESTICULAR DYSGENESIS SYNDROME; US ENVIRONMENTAL PROTECTION AGENCY; WHO; WORLD HEALTH ORGANISATION.;

ANIMALS; BREAST NEOPLASMS; CONSUMER PRODUCT SAFETY; CONTRACEPTIVE AGENTS, FEMALE; COSMETICS; DISORDERS OF SEX DEVELOPMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED PRACTICE; FEMALE; HUMANS; MALE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TERMINOLOGY AS TOPIC; TESTIS;

EID: 84888021181     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2013.10.022     Document Type: Article

References (131)

1. American Council on Science and Health (ACSH), 1999. Endocrine Disruptors. A Scientific Perspective. Available at: http://www.acsh.com/.
2. Ahlborg U.G., Lipwirth L., Titus-Ernstoff L., Hsieh C.C., Hanberg A.J., Trichopoulos D., Adami H.O. Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: as assessment of the biological and epidemiological evidence. Crit. Rev. Toxicol. 1995, 25:463-531.
3. Akre O., Cnattingius S., Bergstroem R., Kvist U., Trichopoulos D., Ekbom A. Human fertility does not decline: evidence from Sweden. Fertil. Steril. 1999, 71(6):1066-1069.
4. Akre O., Boyd H.A., Ahlgren M., Wilbrand K., Westergaard T., Hjalgrim H., Nordenskjöld A., Ekbom A., Melbye M. Maternal and gestanional risk factors for hypospadias. Environ. Health Perspect. 2008, 116(8):1071-1076.
5. Anon. Synergy paper questioned at toxicology meeting. Science 1997, 275(March):1879.
6. Anon. Danish sperm counts spark data dispute. Science 2011, 32(June):1369-1370.
7. Arcaro K.F., Vakharia D.D., Yang Y., Gierthy J.F. Lack of synergy by mixtures of weakly estrogenic hydroxylated polychlorinated biphenyls and pesticides. Environ. Health Perspect. 1998, 106(Suppl. 4):1041.
8. Arnold S.F., Klotz D.M., Collins B.M., Vonier P.M., Guilette L.J., McLachlan J.A. Synergistic activation of estrogen receptor with combination of chemicals. Science 1996, 272:1489-1492.
9. Aschim E.L., Grotmol T., Tretli S., Haugen T.B. Is there an association between maternal weight and the risk of testicular cancer? An epidemiologic study of Norwegian data with emphasis on World War II. Int. J. Cancer 2005, 116:327-330.
10. 14C]-methyl, -propyl and butylparaben in rats after oral, topical or subcutaneous administration. Food Chem. Toxicol. 2012, 50:445-454.
11. Axelsson J., Rylander L., Rignell-Hydborn A., Giewercman A. No secular trend over the last decade in sperm counts among Swedish men from the general population. Hum. Reprod. 2011, 26(5):1012-1016.
12. Bars R., Fegert I., Gross M., Lewis D., Weltje L., Weyers A., Wheeler J.R., Galay-Burgos M. Risk assessment of endocrine-active chemicals: identifying chemicals of regulatory concern. Regul. Toxicol. Pharmacol. 2012, 64:143-154.
13. BfR, 2011. Joint DE-UK Position Paper: Regulatory Definition of an Endocrine Disrupter in Relation to Potential Threat to Human Health. BfR, 16 May, 2011. Available at: http://www.bfr.bund.de/.
14. Boobis A., Budinsky R., Collie S., Crofton K., Embry M., Felter S., Hertzberg R., Kopp D., Mihlan G., Mumtaz M., Price P., Solomon K., Teuschler L., Yang R., Zaleski R. Critical analysis of the literature on low-dose synergy for use in screening chemical mixtures for risk assessment. Crit. Rev. Toxicol. 2011, 41(5):369-383.
15. Bonde J.P., Ramlau-Hansen C.H., Olsen J. Trends in sperm counts: the saga continues. Epidemiology 2011, 22(5):1-4.
16. Borgert C.J., Borgert S.A., Findley K.C. Synergism, antagonism, or additivity of dietary supplements: application of theory to case studies. Thrombosis Res. 2005, 117:123-132.
17. Borgert C.J., Mihaich E.M., Ortego L.S., Bentley K.S., Holmes C.M., Levine S.L., Becker R.A. Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's endocrine disruptor screening program. Regul. Toxicol. Pharmacol. 2011, 61:185-191.
18. Borgert C.J., Sargent E.V., Casella G., Dietrich D.R., McCarty L.S., Golden R.J. The human relevant potency threshold: reducing uncertainty by human calibration of cumulative risk assessments. Regul. Toxicol. Pharmacol 2012, 62:313-328.
19. Borgert C.J., Baker S.P., Mathews J.C. Potency matters: thresholds govern endocrine activity. Regul. Toxicol. Pharmacol. 2013, 10.1016/j.yrtph.2013.06.007.
20. Breithaupt A. A cause without a disease. Eur. Mol. Biol. Org. EMBO Report 2004, 5(1):16.
21. Broschard T.H., Schubert C., Marburger A., Czasch S., Klieber H., von Landenberg F., Kramer P.J. Absence of estrogenic activity of the UV-filter 4-methylbenzylidene camphor in a one-generation reproduction study in rats. Poster shown at the IUTOX International Congress of Toxicology, Paris, 2004 2004, The study has also been summarised in the respective Opinion of the EU SCCS, Available at: http://ec.europa.eu/health/scientific_committees/consumer_safety/index_en.htm.
22. Calabrese E.J., Baldwin L.A., Kostecki P.T., Potter T.L. A toxicologically based weight-of-evidence methodology for the relative ranking of chemicals of endocrine disruption potential. Regul. Toxicol. Pharmacol. 1997, 26:36-40.
23. Carlsen E., Giwercman A., Keiding N., Skakkebaek N.E. Evidence for decreasing quality of semen during the past 50 years. BMJ 1992, 305(6854):609-613.
24. Charles G.D., Gennings C., Tornesi B., Kan H.L., Zacharewski T.R., Bhaskar Gollapudi B., Carney E.W. Analysis of the interaction of phytoestrogens and synthetic chemicals: an in vitro/in vivo comparison. Toxicol. Appl. Pharmacol. 2007, 218(3):280-288.
25. Christen V., Crettaz P., Oberli-Schrammli A., Fent K. Antiandrogenic activity of phthalate mixtures: validity of concentration addition. Toxicol. Appl. Pharmacol. 2012, 259(2):169-172.
26. Cosmetic Ingredient Review (CIR) Final amended report on the safety assessment of methylparaben, ethylparaben, propylparaben, isopropylparaben, butylparaben, isobutylparaben and benzylparaben as used in cosmetic products. Int. J. Toxicol. 2008, 27(Suppl. 4):1-82.
27. Cline J.M., Söderqvist G., Register T.C., Williams J.K., Adams M.R., Von Schoultz B. Assessment of hormonally active agents in the reproductive tract of female nonhuman primates. Toxicol. Pathol. 2001, 29:84-90.
28. Darbre P.D., Aljarrah A., Miller W.R., Coldham N.G., Sauer M.J., Pope G.S. Concentrations of parabens in human breast tumours. J. Appl. Toxicol. 2004, 24(1):5-13.
29. Dekant W., Colnot T. Endocrine effects of chemicals: aspects of hazard identification and human health risk assessment. Toxicol. Lett. 2013, 10.1016/j.toxlet.2013.03.22.
30. Delclos K.B., Bucci T.J., Lomax L.G., Latendresse J.R., Warbritton A., Weiss C.C., Newbold R.R. Effects of dietary genistein exposure during development on male and female CD (Sprague-Dawley) rats. Reprod. Toxicol. 2001, 15(6):647-663.
31. Dietrich D., von Aulock S., Marquart H., et al. Scientifically unfounded precaution drives European Commission's reconmmendations on EDC regulation, while defying common sense, well-established science and risk assessment principles. Toxicol. Lett. 2013, 10.1016/j.toxlet.2013.07.010.
32. Dumas A. Les Mohicans de Paris 1871, 232. M. Lévy Frères (Ed.).
33. ECETOC, 2009. Guidance on identifying endocrine disrupting effects. Technical Report No. 106, European Center of Ecotoxicology and Toxicology, Brussels, Belgium. Available at: http://www.ecetoc.org/.
34. European Food Safety Agency (EFSA) Scientific Opinion on the hazard assessment of endocrine disruptors: scientific criteria for identification of endocrine disruptors and appropriateness of existing test methods for assessing effects mediated by these substances on human health and the environment. EFSA J. 2013, 11(3):3132.
35. EPA, 2012. US Environmental Protection Agency. 13 September, 2012. Endocrine Disruptors Research. Available at: http://www.epa.gov/endocrine/.
36. EU, 2012. European Union. Endocrine Disruptor Site. 4. December, 2012. Available at: http://ec.europa.eu/environment/endocrine/documents/reports_conclusions_en.htm.
37. Fegert ECETOC Florence workshop on risk assessment of endocrine disruptors including the potency concept. Toxicol. Lett. 2013, in press. 10.1016/toxlet.2013.03.027.
38. Fish H. The possible effects of environmental estrogen disrupters on reproductive health. Curr. Urol. Rep. 2000, 1:253-261.
39. Fish H., Golden R.J., Libersen G.L., Hyun G.S., Madsen P., New M.I., Hensle T.W. Maternal age as a risk factor for hypospadias. J. Urol. 2001, 165(3):934-936.
40. Fish H. Declining worldwide sperm counts: disproving a myth. Urol. Clin. N. Am. 2008, 35:137-146.
41. Foster W.G., Agzarian J. Towards less confusing terminology in endocrine disruptor research. J. Toxicol. Environ. Health, Part II 2008, 11:152-161.
42. Gallo D., Mantuano E., Fabrizi M., Ferlini C., Mozzetti S., De Stefano I., Scambia G. Effects of a phytoestrogens-containing soy extract on the growth-inhibitory activity of ICI 182780 in an experimental animal model of estrogen-dependent breast cancer. Endocr. Relat. Cancer 2007, 14(2):317-324.
43. Gazin V., Marsden E., Briffaux J. Propylparaben - 8-week post-weaning juvenile toxicity study with a 26-week treatment-free period in the male Wistar rat by the oral route. US Society of Toxicology Meeting, San Francisco, March 14, 2012 2012, Abstract No 2359.
44. Golden R., Gandy J., Vollmer G. A review of the endocrine activity of parabens and implications for potential risks to human health. Crit. Rev. Toxicol. 2005, 35:435-458.
45. Godman, Gilman Godman and Gilman's The Pharmacological Basis of Therapeutics, Section XIII. Hormones and Hormone Antagonists 2011, McGraw-Hill, New York. 12th ed.
46. Goodwin M., Goodwin K.M., Regnier F. Sex pheromone in the dog. Science 1979, 203(9):559-561.
47. Gori G.B. Regulating endocrine disruptors. Regul. Toxicol. Pharmacol. 2007, 48(1):1-3.
48. Greim H. Chemicals with endocrine-disrupting potential: a threat to human health?. Angew. Chem. Int. Ed. 2005, 44:5568-5574.
49. Guilette L.J., Pickford D.B., Crain D.A., Rooney A.A., Percival H.F. Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in a contaminated environment. Gen. Comp. Endocrin. 1996, 101(1):32-42.
50. Handelsman D.J. Estrogens and falling sperm counts. Reprod. Fertil. Developm. 2001, 13(4):317-324.
51. Hemminki E., Gissler M., Merilainen J. Reproductive effects of in utero exposure to estrogen and progestin drugs. Fertil. Steril. 1998, 71(6):1092-1099.
52. Hoberman A.M., Schreur D.K., Leazer T., Daston G.P., Carthew P., Re T., Loretz L., Mann P. Lack of effect of butylparaben and methylparaben on the reproductive system in male rats. Birth Def. Res. B 2008, 83:128-133.
53. Humphrey C.D. Phytoestrogens and human health effects: weighing up the evidence. Nat. Toxins 1998, 6(2):51-59.
54. Isozaki T., Kumagai H., Ohura M., Hishida A. Natriuretic response to acute sodium chloride or sodium bicarbonate infusion in humans. Miner Electrolyte Metab. 1995, 21(6):383-390.
55. Itoh N., Kayama F., Tatsuki J., Tsukamoto T. Have sperm counts deteriorated over the past 20 years in healthy young Japanese men? Results from the Sapporo area. J. Androl. 2001, 22(1):40-44.
56. IUPHAR, 2013. International Union on Basic and Clinical Pharmacology. IUPHAR-DB receptor database at http://www.iuphar-db.org/.
57. Janjua N.R., Mortensen G.K., Andersson A.M., Kongshoj B., Skakkebaek N.E., Wulf H.C. Systemic uptake of diethyl phthale, dibutyl phthalate, and butyl parabens following whole-body topical application and reproductive and thyroid hormone levels in humans. Environ. Sci. Technol. 2007, 41:5564-5570.
58. Jensen G.K., van Vliet L. Revising the EU strategy on endocrine disruptors: nearing a decisive moment. J. Epidemiol. Commun. Health 2012, 10.1136/jech-2012-201747.
59. Jewell C., Prusakiewicz J.J., Ackermann C., Payne N.A., Fate G., Voorman R., Williams F.M. Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture. Toxicol. Appl. Pharmacol. 2007, 225:221-228.
60. Jobling S., Williams R., Johnson A., Taylor A., Gross-Sorokin M., Nolan M., Tyler C.R., van Aerle R., Santos E., Brighty G. Predicted exposures to steroid estrogens in UK rivers correlate with widespread sexual disruption in wild fish populations. Environ. Health Perspect. 2006, 114(Suppl. 1):32-36.
61. Joffe M. Time trends in biological fertility in Britain. Lancet 2000, 355:1961-1965.
62. Johnson K.J., Heger N.E., Bockelheide K. Of mice and men (and rats): phthalate-induced fetal testis endocrine disruption is species-dependent. Toxicol. Sci. 2012, 129(2):235-248.
63. Jorgensen N., Nordstrom Joensen U., Jensen T.K., Blomberg Jensen M., Almstrup K., Ahlman Olesen I., Juul A., Andersson A.M., Carlsen E., Petersen J.H., Toppari J., Skakkebaek N.E. Human semen quality in the new millennium: a prospective cross-sectional population-based study of 4867 men. BMJ Open 2 2012, 10.1136/bmjopen-2012-000990.
64. Kakehashi A., Tago Y., Yoshida M., Sokuza Y., Wei M., Fukushima S., Wanibuchi H. Hormonally active doses of isoflavones aglycons promote mammary and endometrial carcinogenesis and alter the molecular tumor environment in Donryu rats. Toxicol. Sci. 2012, 126(1):39-51.
65. Kortenkamp A., Faust M. Combined exposures to anti-androgenic chemicals: Steps towards cumulative risk assessment. International Journal of Andrology 2010, 33(2):463-474.
66. Krieger N., Wolff M.S., Hiatt R.A., Rivera M., Vogelman J., Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. JNCI 1994, 86:589-599.
67. Kunz P.Y., Fent K. Estrogenic activity of ternary UV filter mixtures in fish (Pimephales promelas) - an analysis with nonlinear isobolograms. Toxicol. Appl. Pharmacol. 2009, 234:77-88.
68. Kurzer M.S., Xu X. Dietary phytoestrogens. Ann. Rev. Nutr. 1997, 17:353-381.
69. Leary F.J., Resseguie L.J., Kurland L.T., O'Brien P.C., Emslander R.F., Noller K.L. Males exposed in utero to diethylstilbestrol. JAMA 1984, 252(21):2984-2989.
70. Lewis R.W., Billington R., Debruyne E., Gamer A., Lang B., Carpanini F. Recognition of adverse and nonadverse effects in toxicity studies. Toxicol. Pathol. 2002, 30(1):66-74.
71. Li W., Hosseinian F.S., Tsopmo A., Friel J.K., Beta T. Evaluation of antioxidant capacity and aroma quality of breast milk. Nutrition 2009, 25(1):105-114.
72. Lindner H.R. Occurrence of anabolic agents in plants and their importance. Environ. Qual. Safety Suppl. 1976, 151-158.
73. Lübbert H., Leo-Rossberg I., Hammerstein J. Effects of ethinyl estradiol on semen quality and various hormonal parameters in a eugonadal male. Fertil. Steril. 1992, 58(3):603-608.
74. Mallidis C., Cooper T.G., Hellenkemper B., Lablans M., Uckert F., Nieschlag E. Ten year's experience with an external quality control program for semen analysis. Fertil. Steril. 2012, 98(3):611-616.
75. McGlynn K.A., Graubard B.I., Klebanoff M.A., Longnecker M.P. Risk factors for cryptorchidism among populations at differing risks of testicular cancer. Int. J. Epidemiol. 2006, 35(3):787-795.
76. McLachlan J.A. Synergistic effects of environmental estrogens: report withdrawn. Science 1997, 277:462-463.
77. McClain R.M., Wolz E., Davidovich A., Edwards J., Bausch J. Reproductive safety studies with genistein in rats. Food Chem. Toxicol. 2007, 45(8):1319-1332.
78. McMurry C.S., Dickerson R.L. Effect of binary mixtures on hormone concentrations and morphometric endpoints of northern bobwhite quail (Colinus virginianus). Chemosphere 2001, 43:829-837.
79. MEDLINE, 2013. Search for the term "endocrine disruption", January 2013. Available at: http://www.ncbi.nlm.nih.gov/pubmed%3Fterm=endocrine%20disruption.
80. Mense S.M., Hei T.K., Ganju R.K., Bhat H.K. Phytoestrogens and breast cancer prevention: possible mechanisms of action. Environ. Health Perspect. 2008, 116(4):426-433.
81. Mirick D.K., Davis S., Thomas D.B. Antiperspirant use and the risk of breast cancer. J. Natl. Cancer Inst. 2002, 94(20):1578-1580.
82. Myers J.P., Zoeller T., Vom Saal F.S. The clash of old and new concepts in toxicity, with important implications for public health. Environ. Health Perspect. 2009, 117(11):1652-1655.
83. Nilsson R. Endocrine modulators in the food chain and environment. Toxicol. Pathol. 2000, 28(3):420-431.
84. North K., Golding J. A maternal vegetarian diet in pregnancy is associated with hypospadias. BJU Int. 2000, 85(1):107-113.
85. OECD Detailed review paper state of the science on novel in vitro and in vivo screening and testing methods and endpoints for evaluating endocrine disruptors No. 178. ENV/JM/MONO (2012) 2012, 23.
86. Oellermann S.O., Arambel M.J., Wiedmayer R.W., Foote W.J., Marcinkowski D. Annual meeting of the American Society of Animal Science, Logan, Utah, USA, July 28-31. J. Anim. Sci. 1987, 65(Suppl. 1):358.
87. Oishi S. Effects of butylparaben on the male reproductive system in rats. Toxicol. Ind. Health 2001, 17(1):31-39.
88. Pechère-Bertschi A., Maillard M., Stalder H., Bischof P., Fathi M., Brunner H.R., Burnier M. Renal hemodynamic and tubular responses to salt in women using oral contraceptives. Kidney Int. 2003, 64(4):1374-1380.
89. Peeters P.H., Keinan-Boker L., van der Schouw Y.T., Grobbee D.E. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Res. 2003, 77(2):171-183.
90. Piersma A.H., Hernandez L.G., van Benthem J., Muller J.J.A., van Leeuwen R., Vermeire T.G., van Raaij M.T.M. Reproductive toxicants have a threshold of adversity. Crit. Rev. Toxicol. 2011, 41(6):545-554.
91. Pritchett L.E., Atherton K.M., Mutch E., Ford D. Glucuronidation of the soybean isoflavones genistein and daidzein by human liver is related to the levels of UGT1A1 and UGT1A9 activity and alters isoflavone response in the MCF-7 human breast cancer cell line. J. Nutr. Biochem. 2008, 19(11):739-745.
92. Ramlau-Hansen C.H., Olesen A.V., Parrner E.T., Sorensen H.T., Olsen J. Perinatal markers of estrogen exposure and risk of testicular cancer: follow-up of 1,333,873 Danish males born between 1950 and 2002. Cancer Causes Contr. 2009, 20(9):1587-1592.
93. Riddell D., Pacey A., Whittington K. Lack of compliance by UK andrology laboratories with World Health Organization recommendations for sperm morphology assessment. Human Reprod. 2005, 20(12):3441-3445.
94. Rhomberg L.R., Goodman J. Low-dose effects and nonmonotonic dose-responses of endocrine disrupting chemicals: has the case been made?. Regul. Toxicol. Pharmacol. 2012, 64:130-133.
95. Rolland M., LeMoal J., Wagner V., Royère D., DeMouzon J. Decline in semen concentration and morphology in a sample of 26609 men close to the general population between 1989 and 2005 in France. Hum. Reprod. 2012, 10.1093/humrep/des415.
96. Routledge E.J., Parker J., Odum J., Ashby J., Sumpter J.P. Some alkyl hydroxy benzoate preservatives (parabens) are estrogenic. Toxicol. Appl. Pharmacol. 1998, 153:12-19.
97. Rozman K.K., Bhatia J., Calafat A.M., et al. NTP-CERHR expert panel report on the reproductive and developmental toxicity of genistein. Birth Def. Res. B Dev. Reprod. Toxicol. 2006, 77(6):485-638.
98. Safe S.H. Is there an association between exposure to environmental estrogens and breast cancer?. Eviron. Health Perspect. 1997, 105(Suppl. 3):675-678.
99. Safe S.H. Hazard and risk assessment of chemical mixtures using the toxic equivalency factor approach. Environ. Health Perspect. 1998, 106(Suppl. 4):1051-1058.
100. Safe S.H. Endocrine disruptors and human health: is there a problem. Toxicology 2004, 205:3-10.
101. Safe S.H. Clinical correlates of environmental endocrine disruptors. Trends Endocrinol. Metabol. 2005, 16(4):139-144.
102. Saidi J.A., Chang D.T., Goluboff E.T., Bagiella E., Olsen G., Fish H. Declining sperm counts in the United States? A critical review. J. Urol. 1999, 161:460-462.
103. Sandanger T.M., Huber S., Moe M.K., Braazthen T., Leknes H., Lund E. Plasma concentrations of parabens in postmenopausal women and self-reported use of personal care products: the NOWAC postgenome study. J. Expos. Sci. Environ. Epidemiol. 2011, 1-6.
104. Schauer U.M.D., Völkel W., Heusener A., Colnot T., Broschard T.H., von Landenberg F., Dekant W. Kinetics of 3-(4-methylbenzylidene) camphor in rats and humans after dermal application. Toxicol. Appl. Pharmacol. 2006, 216:339-346.
105. Scheike T.H., Rylander L., Carstensen L., Keiding N., Jensen T.K., Stromberg U., Joffe M., Akre O. Time trends in human fecundity in Sweden. Epidemiology 2008, 19(2):191-196.
106. Schlumpf M., Cotton B., Conscience M., Haller V., Steinmann B., Lichtensteiger W. In vitro and in vivo estrogenicity of UV filters. Environ. Health Perspect. 2001, 109(3):239-244.
107. Schumacher G.B., Gill W.B., Hubby M.M., Blough R.R. Semen analysis in males exposed in utero to diethylstilbestrol (DES) or placebo. IRCS Med. Sci. Compend. 1981, 9:100-101.
108. SEER, 2010. Cancer of female breast, US incidence rates, 1975-2008, in situ vs. malignant, by age, females. At http://seer.cancer.gov/.
109. Setchell K.D., Brown N.M., Zhao X., Lindley S.L., Heubi J.E., King E.C., Messina M.J. Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk. Am. J. Clin. Nutr. 2008, 94(5):1284-1294.
110. Storgaard L., Bonde J.P., Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Reprod. Toxicol. 2006, 21(1):4-15.
111. Susser M. What is a cause and how do we know one? A grammar for pragmatic epidemiology. Am. J. Epidemiol. 1991, 133(7):635-648.
112. Swan S.H., Liu F., Hines M., Kruse R.L., Wang C., Redmon J.B., Sparks A., Weiss B. Prenatal phthalate exposure and reduced masculine play in boys. Int. J. Androl. 2009, 32:1-9.
113. Takagi H., Shibutani M., Lee K.Y., Lee H.C., Nishihara M., Uneyama C., Takigami S., Mitsumori K., Hirose K. Lack of modifying effects of genistein on disruption of the reproductive system by perinatal dietary exposure to ethinylestradiol in rats. Reprod. Toxicol. 2004, 18:687-700.
114. Takeda R. Effects of hormonal drugs during pregnancy: from the viewpoint of endocrine disruptors. Congen. Anomal. 2001, 41(3):235.
115. Taubes, G., 2012. Science, pseudoscience, nutritional epidemiology and meat. At: http://garytaubes.com/2012/03/science-pseudoscience-nutritional-epidemiology-and-meat/.
116. Testai E., Galli C.L., Dekant W., Marinovich M., Piersma A.H., Sharpe R.M. A plea for risk assessment of endocrine disrupting chemicals. Toxicology 2013, 10.1016/j.tox.2013.07.018.
117. Thorup J., McLachlan R., Cortes D., Nation T.R., Balic A., Southwell B.R., Hutson J.M. What is new in cyptochidism and hypospadias - a critical review of the testicular dysgenesis hypothesis. J. Pedr. Surg. 2010, 45:2074-2086.
118. Tinwell H., Colombel S., Blanck O., Bars R. The screening of everyday life chemicals in validated assays targeting the pituitary-gonadal axis. Regul. Toxicol. Pharmacol. 2013, 66:184-196.
119. TOXLINE, 2013. Available at: Search on 15 January, 2013. Search term: "endocrine disruptors". http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen%3FTOXLINE.
120. Vandenberg L.N., Colborn T., Hayes T.B., Heindel J.J., Jacobs D.R., Lee D.H., Shioda T., Soto A.N., vom Saal F.S., Welshons W.V., Zoeller T., Peterson Myers J. Hormones an endocrine-disrupting chemical: low-dose effects and nonmonotonic dose responses. Endocr. Rev. 2012, 33(3).
121. Van Meeuven J.A., van den Berg M., Sanderson J.T., Verhoef A., Piersma A.H. Estrgenic effects of mixtures of phyto- and synthetic chemicals on uterine growth in prepubertal rats. Toxicol. Lett. 2007, 170:165-176.
122. Vajda A.M., Barber L.B., Gray J.L., Lopez E.M., Bolden A.M., Schoenfuss H.J., Norris D.O. Demasculinization of male fish by wastewater treatment plant effluent. Aquat. Toxicol. 2011, 103:213-221.
123. Weybridge, 1996. European Workshop on the impact of endocrine disrupters on human health and wildlife. Report of Proceedings. EUR 17549.
124. WHO/IPCS, 2002. International Program on Chemical Safety. Global Assessment of Endocrine Disrupting Chemicals. Available at: http://www.who.int.ipcs/.
125. Wilcox A.J., Baird D.D., Weinberg C.R., Hornsby P.P., Herbst A.L. Fertility in men prenatally exposed to diethylstilbestrol. N. Engl. J. Med. 1995, 332:1411-1416.
126. Wilcox A.J. On sperm counts and data responsibility. Epidemiology 2011, 22(5):1-2.
127. Witorsch R.J.a. Endocrine disruptors: can biological effects and environmental risks be predicted?. Regul. Toxicol. Pharmacol. 2002, 36:118-130.
128. Witorsch R.J. Low-dose in utero effects of xenoestrogens in mice and their relevance to humans: an analytical review of the literature. Food Chem. Toxicol. 2002, 40:905-912.
129. Witorsch R.J., Thomas J.A. Personal care products and endocrine disruption: a critical review of the literature. Crit. Rev. Toxicol. 2010, 40(S3):1-30.
130. Wu K.M., Farelly J.G. Preclinical development of drugs that enhance thyroid hormone metabolism and clearance: inadequacy of using rats as an animal model for predicting human risks in an IND or NDA. Am. J. Therap. 2006, 13:141-144.
131. Zoeller R.T., Brown T.R., Doan L.I., Gore A.C., Skakkebaek N.E., Soto A.M., Woodruff T.J., Vom Saal F.S. Endocrine-disrupting chemicals and public health protection: a statement of principles from the endocrine society. Endocrinology 2012, 153(9). 10.1210/en.2012-1422.